Judith Dunn - Jan 19, 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
President, Research & Development
Signature
/s/ Peter Thomson, as attorney-in-fact for Judith A. Dunn
Stock symbol
FULC
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/21/2022, 03:15 PM
Previous filing
Aug 9, 2021
Next filing
Jun 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +141K $0.00 141K Jan 19, 2022 Common Stock 141K $12.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service.

Remarks:

President, Research & Development